AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI

Clinical trial NCT06708910 · RECRUITING

Trial details

NCT number: NCT06708910
Sponsor: Heinrich-Heine University, Duesseldorf
Status: RECRUITING
Study type: OBSERVATIONAL

HER2 Positive Breast Carcinoma

Start date: 2025-07-18
Primary completion: 2031-03-01
Enrollment: 460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.